Faes Farma SA (FAE) – Company Profile and SWOT Analysis

Faes Farma SA (FAE) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Faes Farma SA (Faes Farma) engages in the research, development, manufacturing, and marketing of prescription medicines, healthcare products, and animal nutrition products. The company focuses on various therapeutic areas such as allergic diseases, gastrointestinal diseases, bone immunomodulation, and pain. The company offers medicines, active substances, cosmetic products, food supplements, nutritional products, and medical devices. It also offers complementary feeds (concentrates), correctors, complete feeds, and supplements for pigs, ruminants, poultry, and aquaculture. Faes Farma offers its products to food and feed customers, including agricultural companies, distributors, and feed manufacturers. It markets the products in Latin America, Asia, Europe, Africa, and the Middle East. Faes Farma is headquartered in Leioa, Spain.

Scope

• Detailed information on Faes Farma SA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Faes Farma SA in the form of a SWOT analysis

• An in-depth view of the business model of Faes Farma SA including a breakdown and examination of key business segments

• News about Faes Farma SA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Faes Farma SA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Faes Farma SA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Faes Farma SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Almirall SA

Laboratorios Farmaceuticos Rovi SA

Laboratorios Richmond SACIF

Grifols SA

Vifor Pharma Management Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Faes Farma SA - Key Facts

Faes Farma SA - Key Employees

Faes Farma SA - Key Employee Biographies

Faes Farma SA - Major Products and Services

Faes Farma SA - History

Faes Farma SA - Company Statement

Faes Farma SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Faes Farma SA - Business Description

Business Segment: Animal Nutrition and Health

Overview

Performance

Business Segment: Pharmaceutical and Healthcare Specialties

Overview

Performance

Business Segment: Pharmaceutical Raw Materials

Overview

Performance

Geographical Segment: Domestic

Performance

Geographical Segment: International

Performance

R&D Overview

Faes Farma SA - Corporate Strategy

Faes Farma SA - SWOT Analysis

SWOT Analysis - Overview

Faes Farma SA - Strengths

Faes Farma SA - Weaknesses

Faes Farma SA - Opportunities

Faes Farma SA - Threats

Faes Farma SA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Faes Farma SA, Recent Deals Summary

Section 5 – Company’s Recent Developments

Apr 30, 2026: Faes Farma Exceeds 200 Million in Revenue (31%) and Increases Net Profit by 9% in First Quarter

Nov 04, 2025: Faes Farma Reports 15% Revenue Growth to €454 Million

Jul 30, 2025: Faes Farma appoints Isabel Nájera as Chief Scientific Officer and member of the Global Executive Team

Jul 24, 2025: Faes Farma Increases Revenues

12.3% to

307.4 Million Euros

Apr 21, 2025: Faes Farma Hires Isabel Najera as Chief Scientific Officer and Member of the Global Executive Team.

Apr 01, 2025: CIC bioGUNE Receives the Development and Innovation Management team from FAES Farma

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Faes Farma SA, Key Facts

Faes Farma SA, Key Employees

Faes Farma SA, Key Employee Biographies

Faes Farma SA, Major Products and Services

Faes Farma SA, History

Faes Farma SA, Subsidiaries

Faes Farma SA, Key Competitors

Faes Farma SA, Ratios based on current share price

Faes Farma SA, Annual Ratios

Faes Farma SA, Annual Ratios (Cont…1)

Faes Farma SA, Annual Ratios (Cont…2)

Faes Farma SA, Interim Ratios

Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Faes Farma SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Faes Farma SA, Performance Chart (2020 – 2024)

Faes Farma SA, Ratio Charts

Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports